@EASLedu brings you the latest on #liver research & education. Visit #EASLCampus
-----------------
EASL does not express any political opinion.
RT ≠ endorsement
Missed out on EASL 2026, or simply want to revisit some of the topics from the meeting? Join our Virtual Live Streamed Falk Futures Meeting 09/06 for our post @EASLedu debrief session with Dr Deepak Joshi & @YiannisKallis More info or to register visit: https://t.co/JgMBKzWPri
Need to encourage more high quality liver transplant research @EASLedu#EASLcongress. It’s the reason many hepatologists went into their field of medicine
💚Last day of #EASLCongress and the perfect opportunity to visit the Love Your Liver Village in front of Fira Barcelona until 15:00pm!
Get a free, non-invasive liver test, and meet public health professionals ready to talk about all things liver health!
😍What participants say:
- "I’ve been living in front of the Congress centre for seven years and this is the very first time a conference has done something to give back to the community."
- "I just did a Fibroscan with Francesca and she was just amazing. Speaking in Spanish and English, I felt right at home and like it wasn’t a typical patient-provider interaction. It felt comfortable and just really great."
🧫 Infection & HE in cirrhosis
🗣️ T. Thévenot | #EASLCongress
🔬 Rifaximin & cotrimoxazole (ASEPTIC trial) for 1 PF SBP prophylaxis → no benefit — Baveno VIII agrees
⚠️ Antibiotic prophylaxis in GI bleeding also questioned in Child-Pugh A pts
💡 Future: albumin, probiotics & FMT
Massive congrats to one of the best to ever do it. A superb supervisor, mentor, academic and clinician.
Very well deserved 👏🏾
@UoBinfectionsch@uhbtrust@unibirm_CMH
Join us in EASL Studio, Hall 8.0, to discover the Congress Highlights.
🤔Which abstracts in each topic track stood out?
🧐What key findings emerged?
🤷♀️How will they shape the future of hepatology?
📍EASL Studio (Hall 8.0)
⌚Today, 14:45-15:45 CEST
@CornbergMarkus@JasmohanBajaj@hlcortezpinto@Alexfornergon@horstef@SilviaAffo
#EASLcongress #Bestof
🧫 Ongoing Phase III RCTs in ACLF
🗣️ J. Fernández | #EASLCongress
🔬 Key results:
- G-CSF → conflicting (✅ India vs ❌ Europe)
- DIALIVE, ELAD & plasma exchange → more data needed
💡 New trial designs (DOOR, adaptive) needed — esp. severe ACLF (≥3 OF)